Why the study?
Epidemiological and clinical studies on prehypertension, white coat hypertension, and masked hypertension are still limited, yet these conditions carry higher cardiovascular risk than normotension and require guidance on diagnosis and management.
This Brazilian position paper establishes standardized diagnostic thresholds using out-of-office blood pressure monitoring and outlines risk-stratified lifestyle and pharmacological management for prehypertension, white coat hypertension, and masked hypertension.
Answers are grounded in this paper and cite their sources.
May help Brazilian clinicians avoid unnecessary drug therapy; extends prior consensus with risk-stratified thresholds.
Arterial blood pressure (BP) is a very useful variable in clinical practice. Its measurement is simple, inexpensive and easy; it is worth noting that BP should be accurately obtained, following the recommendations of the VI Brazilian Guidelines on Hypertension (DBH VI)1. Office BP measurement is the central parameter for the diagnosis, treatment and follow-up of systemic arterial hypertension (SAH), being directly, continuously and independently related to the risk of fatal and non-fatal cardiovascular (CV) events1-3. Thus, the consideration of BP values closer to the upper limits of normality, the so-called prehypertension (PH)2, and intervention on those values have been emphasized over the last decade, because PH represents an important opportunity to prevent established SAH, contributing to reduce the associated CV risk. Repeated BP measurement at the office allows the diagnosis of hypertension and normotension. To better assess BP behavior, there are methods that analyze BP by using a higher number of measurements, minimizing interferences of the environment, situation and observer. Those alternatives are as follows: 24-hour ambulatory BP monitoring (ABPM); and dwelling BP measurement [home BP monitoring (HBPM) and BP self-measurement (BPSM)]. Based on those methods, two other BP classifications were adopted: white coat hypertension (WCH) and masked hypertension (MH)1,3-5 (Figure 1). Figure 1 Classification of blood pressure behavior considering office BP, ABPM and home BP measurements1. ABPM: ambulatory blood pressure monitoring; BP: blood pressure. Epidemiological and clinical studies on those conditions are still limited; however, they deserve attention because of their higher CV risk as compared with normotension6,7. This document represents the position of the Brazilian Society of Cardiology Arterial Hypertension Department (DHA/SBC) on the diagnosis and non-drug and drug therapy for PH, WCH and MH, aiming at contributing to a better clinical practice.
No takes yet. Share an insight, caveat, or question.
Alessi et al. (2014) studied Prehypertension, White Coat Hypertension, and Masked Hypertension. Ambulatory blood pressure monitoring (ABPM), home blood pressure monitoring (HBPM), lifestyle changes, and antihypertensive drug therapy was evaluated on Diagnosis and management of prehypertension, white coat hypertension, and masked hypertension. The Brazilian Society of Cardiology recommends out-of-office blood pressure monitoring and lifestyle changes for prehypertension, white coat, and masked hypertension, reserving drug therapy for masked hypertension and high-risk individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: